000919.SZ
金陵药业
SZSE · Healthcare · C 制造业 · CN
CNY 6.51
−1.96%Margins
Gross margin
21.4%
EBITDA margin
7.6%
EBIT margin
2.4%
Net margin
1.9%
FCF margin
4.1%
1.5%
Return on equity
1.0%
Return on assets
1.9%
Return on invested capital
0.52x
Asset turnover
CNY 230.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026